TRANDOLAPRIL TABLETS

TRANDOLAPRIL TABLETS was reported 2034 times

TRANDOLAPRIL TABLETS is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DORSAL RAMUS SYNDROME 5 0.5000
1 HLA-B*27 POSITIVE 5 0.0357
2 UMBILICAL DISCHARGE 3 0.0349
3 ITCHING SCAR 4 0.0310
4 BACTERIAL TEST 9 0.0302
5 ACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 4 0.0282
6 ENDOMETRIAL ABLATION 10 0.0280
7 ENTEROBACTER PNEUMONIA 4 0.0256
8 HYPERTENSIVE ENCEPHALOPATHY 13 0.0219
9 SUBSTANCE USE 33 0.0211
10 ELECTROCARDIOGRAM Q WAVES 2 0.0196
11 OESOPHAGEAL OBSTRUCTION 15 0.0173
12 GASTROINTESTINAL MUCOSA HYPERAEMIA 5 0.0169
13 METAPLASIA 7 0.0148
14 JUGULAR VEIN DISTENSION 8 0.0141
15 PROSTATISM 2 0.0136
16 HEPATIC ISCHAEMIA 4 0.0129
17 RED BLOOD CELLS URINE POSITIVE 12 0.0124
18 CANDIDA PNEUMONIA 4 0.0124
19 PROSTATIC ADENOMA 2 0.0120
20 ANTI-ERYTHROPOIETIN ANTIBODY POSITIVE 3 0.0120
21 BEZOAR 16 0.0116
22 FEBRILE NONHAEMOLYTIC TRANSFUSION REACTION 2 0.0106
23 PYELONEPHRITIS CHRONIC 2 0.0106
24 DILATED CARDIOMYOPATHY 10 0.0099
25 BRONCHIAL WALL THICKENING 7 0.0097
26 WHITE COAT HYPERTENSION 5 0.0092
27 COLECTOMY TOTAL 5 0.0090
28 JOINT ANKYLOSIS 5 0.0088
29 ELECTROCARDIOGRAM Q WAVE ABNORMAL 2 0.0085
30 SPONDYLOARTHROPATHY 5 0.0083
31 PROSTATIC SPECIFIC ANTIGEN DECREASED 3 0.0079
32 OESOPHAGEAL HAEMORRHAGE 9 0.0068
33 WAIST CIRCUMFERENCE INCREASED 7 0.0068
34 SINOATRIAL BLOCK 4 0.0067
35 RENAL HYPERTENSION 2 0.0064
36 WHITE BLOOD CELLS URINE POSITIVE 12 0.0064
37 ACROMEGALY 2 0.0063
38 ARTERIAL DISORDER 12 0.0063
39 ANTICOAGULATION DRUG LEVEL INCREASED 2 0.0062
40 INTESTINAL ANASTOMOSIS 4 0.0062
41 BREAST HAEMORRHAGE 2 0.0061
42 POUCHITIS 5 0.0058
43 PHARYNGEAL PARAESTHESIA 9 0.0057
44 BLOOD GASES ABNORMAL 3 0.0056
45 GASTROENTERITIS ESCHERICHIA COLI 3 0.0055
46 NASAL TURBINATE HYPERTROPHY 2 0.0053
47 BODY MASS INDEX INCREASED 7 0.0052
48 PANCREAS INFECTION 2 0.0050
49 PHLEBITIS SUPERFICIAL 2 0.0047
50 CUTANEOUS SARCOIDOSIS 2 0.0046
51 GLOMERULONEPHRITIS MEMBRANOUS 5 0.0043
52 NODAL RHYTHM 6 0.0041
53 NORMOCYTIC ANAEMIA 6 0.0041
54 ORTHOPNOEA 13 0.0041
55 VENTRICULAR HYPOKINESIA 12 0.0037
56 PERIORBITAL CELLULITIS 2 0.0037
57 RENAL ISCHAEMIA 2 0.0037
58 SUSPECTED COVID-19 12 0.0036
59 OPHTHALMIC HERPES SIMPLEX 2 0.0035
60 LICHEN PLANUS 8 0.0034
61 SMALL INTESTINAL RESECTION 4 0.0034
62 ATYPICAL FRACTURE 2 0.0032
63 INTRACRANIAL MASS 3 0.0032
64 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 5 0.0031
65 DYSPNOEA AT REST 9 0.0031
66 CONTINUOUS HAEMODIAFILTRATION 3 0.0031
67 CARDIAC FAILURE CHRONIC 13 0.0030
68 BRADYARRHYTHMIA 5 0.0030
69 URINE ABNORMALITY 13 0.0029
70 DRUG LEVEL ABOVE THERAPEUTIC 13 0.0028
71 WRONG PRODUCT ADMINISTERED 19 0.0028
72 PUBIS FRACTURE 2 0.0028
73 AZOTAEMIA 11 0.0028
74 DRUG-DISEASE INTERACTION 2 0.0027
75 LUNG OPACITY 7 0.0027
76 ABDOMINAL MASS 7 0.0026
77 CHEST X-RAY ABNORMAL 8 0.0026
78 DEPRESSION SUICIDAL 9 0.0026
79 DILATATION ATRIAL 3 0.0026
80 HYPERAEMIA 5 0.0025
81 LUNG CONSOLIDATION 7 0.0025
82 INTERVERTEBRAL DISC SPACE NARROWING 2 0.0025
83 HELICOBACTER GASTRITIS 3 0.0024
84 RALES 14 0.0024
85 THERAPEUTIC REACTION TIME DECREASED 7 0.0024
86 BLOOD PRESSURE DIASTOLIC ABNORMAL 6 0.0024
87 SERUM FERRITIN DECREASED 4 0.0023
88 CARDIOPULMONARY FAILURE 9 0.0023
89 DIASTOLIC DYSFUNCTION 7 0.0023
90 SPONDYLITIS 8 0.0022
91 LIGAMENT DISORDER 2 0.0022
92 PNEUMONIA KLEBSIELLA 4 0.0022
93 DIABETIC METABOLIC DECOMPENSATION 3 0.0022
94 HYPERMETROPIA 2 0.0021
95 ARNOLD-CHIARI MALFORMATION 2 0.0021
96 POTENTIATING DRUG INTERACTION 7 0.0021
97 BRONCHITIS CHRONIC 5 0.0020
98 OCCULT BLOOD POSITIVE 4 0.0020
99 ORGANISING PNEUMONIA 10 0.0020
100 HYPOPNOEA 7 0.0020
101 INFREQUENT BOWEL MOVEMENTS 5 0.0020
102 ATRIOVENTRICULAR BLOCK SECOND DEGREE 6 0.0020
103 LACTIC ACIDOSIS 64 0.0020
104 BRAIN STEM INFARCTION 2 0.0020
105 CARDIOGENIC SHOCK 28 0.0019
106 CAROTID ARTERIOSCLEROSIS 2 0.0019
107 POLYCYTHAEMIA 4 0.0019
108 VENTRICULAR ARRHYTHMIA 7 0.0019
109 SINUS ARREST 3 0.0019
110 HYPOMANIA 7 0.0019
111 NON-CARDIAC CHEST PAIN 6 0.0019
112 TOTAL LUNG CAPACITY DECREASED 3 0.0019
113 PANCREATIC MASS 2 0.0019
114 HYPERLACTACIDAEMIA 5 0.0019
115 ENDOTRACHEAL INTUBATION 5 0.0018
116 PULMONARY GRANULOMA 2 0.0018
117 PANCREATITIS NECROTISING 4 0.0017
118 SPONDYLOLISTHESIS 3 0.0017
119 ENCEPHALITIS VIRAL 2 0.0016
120 PENILE SWELLING 2 0.0016
121 PLATELET DISORDER 4 0.0016
122 NECROTISING COLITIS 2 0.0016
123 DIABETIC COMPLICATION 4 0.0016
124 LEFT ATRIAL DILATATION 2 0.0016
125 MENOPAUSE 4 0.0016
126 CARDIAC VENTRICULAR THROMBOSIS 2 0.0015
127 PSYCHOTIC DISORDER 45 0.0015
128 HYPOGLYCAEMIC UNCONSCIOUSNESS 3 0.0015
129 IMPLANTABLE DEFIBRILLATOR INSERTION 2 0.0015
130 ATRIOVENTRICULAR BLOCK COMPLETE 10 0.0015
131 NIPPLE PAIN 3 0.0015
132 IMPULSE-CONTROL DISORDER 3 0.0015
133 HEPATIC FIBROSIS 5 0.0015
134 BODY TEMPERATURE FLUCTUATION 3 0.0014
135 DILATATION VENTRICULAR 3 0.0014
136 ANAEMIA MACROCYTIC 3 0.0014
137 CORONARY ARTERY STENOSIS 7 0.0014
138 DRUG SPECIFIC ANTIBODY PRESENT 9 0.0014
139 MUTISM 2 0.0014
140 OBSTRUCTIVE SLEEP APNOEA SYNDROME 2 0.0014
141 SINUS BRADYCARDIA 13 0.0013
142 HYPERAESTHESIA 11 0.0013
143 ADENOCARCINOMA 3 0.0013
144 HAEMORRHAGIC TRANSFORMATION STROKE 2 0.0013
145 HYPERKALAEMIA 45 0.0013
146 SPINAL PAIN 15 0.0013
147 DUODENAL ULCER 9 0.0013
148 OSTEOSCLEROSIS 2 0.0013
149 MYOPIA 3 0.0013
150 RENAL CYST 10 0.0013
151 VISUAL FIELD DEFECT 9 0.0012
152 AORTIC VALVE DISEASE 2 0.0012
153 TRANSPLANT FAILURE 3 0.0012
154 BODY TEMPERATURE DECREASED 12 0.0012
155 BLOOD IMMUNOGLOBULIN G DECREASED 3 0.0012
156 ACUTE CORONARY SYNDROME 10 0.0012
157 ANTIBODY TEST POSITIVE 2 0.0012
158 TACHYARRHYTHMIA 3 0.0012
159 CONTRAINDICATED PRODUCT PRESCRIBED 2 0.0012
160 VAGINAL DISCHARGE 12 0.0012
161 INTESTINAL STENOSIS 5 0.0012
162 HEPATORENAL SYNDROME 2 0.0012
163 HAEMODYNAMIC INSTABILITY 9 0.0012
164 POOR PERIPHERAL CIRCULATION 5 0.0012
165 LEFT VENTRICULAR HYPERTROPHY 5 0.0012
166 AORTIC ARTERIOSCLEROSIS 3 0.0012
167 HEPATIC LESION 5 0.0012
168 POLYMYOSITIS 2 0.0011
169 AORTIC VALVE STENOSIS 2 0.0011
170 TACHYPNOEA 15 0.0011
171 CONDUCTION DISORDER 2 0.0011
172 HYPOTHERMIA 11 0.0011
173 COAGULOPATHY 18 0.0011
174 BLOOD PRESSURE SYSTOLIC INCREASED 21 0.0011
175 INTESTINAL PERFORATION 12 0.0011
176 PULMONARY CONGESTION 14 0.0011
177 INFECTED SKIN ULCER 2 0.0011
178 BLOOD BICARBONATE DECREASED 2 0.0011
179 PANCREATIC CYST 2 0.0010
180 HYPOREFLEXIA 2 0.0010
181 FIBULA FRACTURE 3 0.0010
182 HYPERTONIC BLADDER 3 0.0010
183 COMA SCALE ABNORMAL 3 0.0010
184 OCULAR HYPERTENSION 2 0.0010
185 GASTROINTESTINAL NECROSIS 3 0.0010
186 LUMBAR SPINAL STENOSIS 3 0.0010
187 CORONARY ARTERY OCCLUSION 14 0.0010
188 DECREASED INTEREST 6 0.0010
189 EXTRASYSTOLES 7 0.0010
190 BLOOD PRESSURE INADEQUATELY CONTROLLED 6 0.0010
191 DEVICE RELATED SEPSIS 2 0.0010
192 BREAST DISORDER 2 0.0010
193 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 4 0.0010
194 ISCHAEMIC CARDIOMYOPATHY 3 0.0010
195 DUODENITIS 3 0.0010
196 GLOMERULAR FILTRATION RATE DECREASED 12 0.0010
197 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 10 0.0010
198 HYPERURICAEMIA 4 0.0010
199 PORTAL HYPERTENSION 3 0.0010
200 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 6 0.0010
201 VENTRICULAR EXTRASYSTOLES 10 0.0010
202 LIVEDO RETICULARIS 2 0.0010
203 MYOPATHY 8 0.0009
204 ANGINA UNSTABLE 6 0.0009
205 EXPOSED BONE IN JAW 2 0.0009
206 HYPOVENTILATION 3 0.0009
207 THROMBOSIS IN DEVICE 3 0.0009
208 DIVERTICULUM INTESTINAL 4 0.0009
209 DIABETIC NEPHROPATHY 2 0.0009
210 MELAENA 20 0.0009
211 VENTRICULAR TACHYCARDIA 15 0.0009
212 CYTOLYTIC HEPATITIS 3 0.0009
213 OBSTRUCTIVE AIRWAYS DISORDER 10 0.0009
214 PARESIS 2 0.0009
215 CARDIOMEGALY 11 0.0009
216 HEPATOCELLULAR DAMAGE 2 0.0009
217 COMPUTERISED TOMOGRAM ABNORMAL 2 0.0009
218 DISLOCATION OF VERTEBRA 2 0.0009
219 APLASIA PURE RED CELL 3 0.0009
220 GASTRITIS EROSIVE 4 0.0009
221 HAEMATOCRIT DECREASED 17 0.0009
222 JAUNDICE CHOLESTATIC 3 0.0008
223 RENAL FAILURE ACUTE 36 0.0008
224 AGGRESSION 42 0.0008
225 ANKYLOSING SPONDYLITIS 11 0.0008
226 HEPARIN-INDUCED THROMBOCYTOPENIA 4 0.0008
227 BLOOD PRESSURE SYSTOLIC ABNORMAL 2 0.0008
228 MUCOUS STOOLS 4 0.0008
229 INTRAVENTRICULAR HAEMORRHAGE 2 0.0008
230 ORTHOSTATIC HYPOTENSION 14 0.0008
231 CATHETER SITE HAEMORRHAGE 2 0.0008
232 ENDODONTIC PROCEDURE 2 0.0008
233 RESPIRATORY RATE INCREASED 7 0.0008
234 CARDIOTOXICITY 7 0.0008
235 ILEOSTOMY 2 0.0008
236 HYPOGLYCAEMIA 38 0.0008
237 RENAL FAILURE CHRONIC 6 0.0008
238 CATHETER SITE PAIN 2 0.0008
239 EPIGASTRIC DISCOMFORT 3 0.0008
240 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 2 0.0008
241 INTERVERTEBRAL DISC DEGENERATION 7 0.0008
242 TRICUSPID VALVE INCOMPETENCE 6 0.0008
243 OBESITY 12 0.0008
244 ABSCESS 12 0.0008
245 HEPATIC STEATOSIS 14 0.0008
246 GINGIVITIS 4 0.0007
247 BRADYPNOEA 2 0.0007
248 COLITIS ISCHAEMIC 5 0.0007
249 METASTASES TO LYMPH NODES 5 0.0007
250 CHONDROPATHY 2 0.0007
251 POISONING DELIBERATE 7 0.0007
252 SLEEP APNOEA SYNDROME 14 0.0007
253 POLYURIA 6 0.0007
254 HICCUPS 6 0.0007
255 ORAL FUNGAL INFECTION 2 0.0007
256 ECCHYMOSIS 5 0.0007
257 PANCREATITIS ACUTE 16 0.0007
258 ATYPICAL FEMUR FRACTURE 2 0.0007
259 PULMONARY TOXICITY 5 0.0007
260 CEREBRAL THROMBOSIS 2 0.0007
261 FORCED EXPIRATORY VOLUME DECREASED 2 0.0007
262 AORTIC VALVE INCOMPETENCE 3 0.0007
263 INTERVERTEBRAL DISC DISORDER 3 0.0007
264 RETINAL HAEMORRHAGE 5 0.0007
265 SPINAL FRACTURE 14 0.0007
266 ANURIA 6 0.0007
267 POOR QUALITY SLEEP 15 0.0007
268 GASTROENTERITIS 10 0.0007
269 HYPOVOLAEMIA 4 0.0007
270 SPINAL OSTEOARTHRITIS 6 0.0007
271 PARONYCHIA 3 0.0007
272 GRIP STRENGTH DECREASED 6 0.0007
273 SLEEP DISORDER 48 0.0007
274 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 6 0.0007
275 BLOOD CREATINE INCREASED 3 0.0007
276 POOR VENOUS ACCESS 7 0.0007
277 OXYGEN SATURATION DECREASED 38 0.0007
278 CATARACT OPERATION 4 0.0007
279 CREPITATIONS 2 0.0007
280 ATYPICAL PNEUMONIA 2 0.0007
281 BLOOD PRESSURE SYSTOLIC DECREASED 3 0.0007
282 PROSTATITIS 2 0.0007
283 SYNOVIAL CYST 3 0.0006
284 ATRIOVENTRICULAR BLOCK 5 0.0006
285 TENDONITIS 10 0.0006
286 SCOLIOSIS 4 0.0006
287 COORDINATION ABNORMAL 9 0.0006
288 APHTHOUS ULCER 5 0.0006
289 PERFORMANCE STATUS DECREASED 3 0.0006
290 PELVIC FRACTURE 5 0.0006
291 TIBIA FRACTURE 3 0.0006
292 BILE DUCT STONE 2 0.0006
293 COLD SWEAT 11 0.0006
294 MULTIPLE DRUG OVERDOSE INTENTIONAL 2 0.0006
295 DIABETES MELLITUS INADEQUATE CONTROL 11 0.0006
296 RASH VESICULAR 3 0.0006
297 HAEMORRHOIDAL HAEMORRHAGE 3 0.0006
298 FACET JOINT SYNDROME 2 0.0006
299 HEPATIC NEOPLASM 2 0.0006
300 MULTIPLE DRUG OVERDOSE 3 0.0006
301 ARTERIOSCLEROSIS CORONARY ARTERY 4 0.0006
302 PNEUMONIA ASPIRATION 15 0.0006
303 ANXIETY DISORDER 2 0.0006
304 INTERNATIONAL NORMALISED RATIO INCREASED 17 0.0006
305 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 3 0.0006
306 DRUG INTERACTION 94 0.0006
307 POSTOPERATIVE WOUND INFECTION 4 0.0006
308 PHLEBITIS 3 0.0006
309 BRONCHOPNEUMONIA 2 0.0006
310 NEPHROTIC SYNDROME 4 0.0006
311 BLOOD PRESSURE FLUCTUATION 14 0.0006
312 PUSTULAR PSORIASIS 2 0.0006
313 VARICOSE VEIN 3 0.0006
314 STOMACH DISCOMFORT 3 0.0006
315 JOINT EFFUSION 4 0.0006
316 FAILURE TO THRIVE 3 0.0006
317 THERAPY PARTIAL RESPONDER 9 0.0006
318 NOCTURIA 7 0.0006
319 HYPERTRANSAMINASAEMIA 4 0.0006
320 HYPOMAGNESAEMIA 8 0.0006
321 HYPERREFLEXIA 2 0.0006
322 CAROTID ARTERY STENOSIS 2 0.0006
323 DEFAECATION URGENCY 4 0.0006
324 GASTRITIS 15 0.0006
325 HEART RATE DECREASED 20 0.0006
326 EMBOLIC STROKE 2 0.0006
327 ANGIOEDEMA 25 0.0006
328 HAEMORRHOIDS 11 0.0006
329 PALLOR 15 0.0006
330 CARDIAC FAILURE 44 0.0005
331 GENERALISED TONIC-CLONIC SEIZURE 9 0.0005
332 DRUG LEVEL INCREASED 9 0.0005
333 INTRACRANIAL PRESSURE INCREASED 3 0.0005
334 HAEMOPTYSIS 15 0.0005
335 ERYTHEMA MULTIFORME 5 0.0005
336 ARTERIOSCLEROSIS 5 0.0005
337 CATHETER SITE INFECTION 2 0.0005
338 CIRCULATORY COLLAPSE 9 0.0005
339 BRADYCARDIA 28 0.0005
340 GASTRIC INFECTION 2 0.0005
341 BOWEL MOVEMENT IRREGULARITY 4 0.0005
342 HERPES VIRUS INFECTION 3 0.0005
343 MUSCLE RUPTURE 2 0.0005
344 THROAT IRRITATION 23 0.0005
345 ELECTROCARDIOGRAM ABNORMAL 4 0.0005
346 PROSTATOMEGALY 2 0.0005
347 HERPES ZOSTER 29 0.0005
348 GALLBLADDER DISORDER 9 0.0005
349 CREATININE RENAL CLEARANCE DECREASED 2 0.0005
350 CANDIDIASIS 2 0.0005
351 HEPATITIS CHOLESTATIC 3 0.0005
352 GAMMA-GLUTAMYLTRANSFERASE INCREASED 11 0.0005
353 INTERNATIONAL NORMALISED RATIO DECREASED 2 0.0005
354 DRY THROAT 5 0.0005
355 ABNORMAL FAECES 4 0.0005
356 MOBILITY DECREASED 35 0.0005
357 OLIGURIA 3 0.0005
358 ILEUS 6 0.0005
359 CONGESTIVE CARDIOMYOPATHY 2 0.0005
360 HYPONATRAEMIA 27 0.0005
361 DYSPNOEA EXERTIONAL 18 0.0005
362 HAEMODIALYSIS 4 0.0005
363 LIP OEDEMA 2 0.0005
364 ESCHERICHIA URINARY TRACT INFECTION 2 0.0005
365 LUNG DISORDER 23 0.0005
366 DIVERTICULITIS 13 0.0005
367 PURULENT DISCHARGE 2 0.0005
368 INTENTIONAL OVERDOSE 30 0.0005
369 ANOREXIA 6 0.0005
370 NIGHT SWEATS 15 0.0005
371 MULTI-ORGAN FAILURE 8 0.0005
372 TOXICITY TO VARIOUS AGENTS 78 0.0005
373 OSTEOPOROSIS 19 0.0005
374 OCULAR ICTERUS 2 0.0005
375 ATRIOVENTRICULAR BLOCK FIRST DEGREE 2 0.0005
376 BLOOD CREATININE INCREASED 30 0.0005
377 DYSGRAPHIA 3 0.0005
378 TOOTH INFECTION 6 0.0005
379 HAEMORRHAGIC ANAEMIA 2 0.0005
380 ANGINA PECTORIS 13 0.0005
381 EJECTION FRACTION DECREASED 7 0.0004
382 JOINT RANGE OF MOTION DECREASED 6 0.0004
383 BREAST MASS 3 0.0004
384 IRON DEFICIENCY 2 0.0004
385 ACUTE KIDNEY INJURY 68 0.0004
386 SINUS CONGESTION 6 0.0004
387 UVEITIS 6 0.0004
388 BLOOD LACTATE DEHYDROGENASE INCREASED 7 0.0004
389 MITRAL VALVE INCOMPETENCE 5 0.0004
390 ACUTE MYOCARDIAL INFARCTION 13 0.0004
391 RENAL IMPAIRMENT 37 0.0004
392 MYOCARDIAL ISCHAEMIA 5 0.0004
393 RESPIRATORY FAILURE 32 0.0004
394 IMMUNE THROMBOCYTOPENIA 2 0.0004
395 BLOOD PRESSURE DIASTOLIC INCREASED 2 0.0004
396 LARGE INTESTINE POLYP 3 0.0004
397 ARTHRITIS 34 0.0004
398 LARGE INTESTINE PERFORATION 3 0.0004
399 NEPHROGENIC ANAEMIA 2 0.0004
400 BLOOD POTASSIUM INCREASED 7 0.0004
401 FLANK PAIN 4 0.0004
402 BLOOD IRON DECREASED 5 0.0004
403 BLOOD UREA INCREASED 7 0.0004
404 FAECAL INCONTINENCE 2 0.0004
405 HUMERUS FRACTURE 2 0.0004
406 ATELECTASIS 4 0.0004
407 CEREBRAL INFARCTION 10 0.0004
408 COELIAC DISEASE 4 0.0004
409 HEPATOMEGALY 4 0.0004
410 METABOLIC ACIDOSIS 13 0.0004
411 BLOOD PRESSURE DIASTOLIC DECREASED 3 0.0004
412 BLOOD PRESSURE DECREASED 27 0.0004
413 LIVER DISORDER 18 0.0004
414 INFLAMMATORY MARKER INCREASED 2 0.0004
415 HEPATIC ENZYME ABNORMAL 2 0.0004
416 DERMATITIS EXFOLIATIVE 2 0.0004
417 HEART RATE IRREGULAR 9 0.0004
418 ERYSIPELAS 2 0.0004
419 HYPOXIA 14 0.0004
420 DERMATITIS ALLERGIC 5 0.0004
421 TOXIC SKIN ERUPTION 4 0.0004
422 PRODUCT ADMINISTRATION ERROR 8 0.0004
423 KLEBSIELLA INFECTION 2 0.0004
424 MUSCLE ATROPHY 5 0.0004
425 CORONARY ARTERIAL STENT INSERTION 2 0.0004
426 PATHOLOGICAL FRACTURE 2 0.0004
427 CARDIOVASCULAR DISORDER 10 0.0004
428 DYSLIPIDAEMIA 2 0.0004
429 DYSPHONIA 23 0.0004
430 ACIDOSIS 3 0.0004
431 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 2 0.0004
432 FEMORAL NECK FRACTURE 2 0.0004
433 PRODUCT TEMPERATURE EXCURSION ISSUE 2 0.0004
434 PERIPHERAL VASCULAR DISORDER 2 0.0004
435 BENIGN PROSTATIC HYPERPLASIA 2 0.0004
436 LEUKOCYTOSIS 7 0.0004
437 C-REACTIVE PROTEIN INCREASED 14 0.0004
438 PULMONARY HAEMORRHAGE 3 0.0004
439 CARDIO-RESPIRATORY ARREST 16 0.0004
440 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 7 0.0004
441 COMA 18 0.0004
442 HALLUCINATION, AUDITORY 6 0.0004
443 SENSORY DISTURBANCE 6 0.0004
444 HIP FRACTURE 12 0.0004
445 HYPERTENSION 79 0.0004
446 BRUXISM 2 0.0004
447 HYPOTENSION 74 0.0004
448 COUGH 102 0.0004
449 EMBOLISM 3 0.0004
450 GASTRIC ULCER HAEMORRHAGE 2 0.0004
451 EOSINOPHIL COUNT INCREASED 3 0.0004
452 RASH MACULO-PAPULAR 8 0.0004
453 APHONIA 5 0.0004
454 SKIN INFECTION 4 0.0004
455 ACUTE PULMONARY OEDEMA 2 0.0004
456 SINUS DISORDER 7 0.0004
457 OEDEMA PERIPHERAL 43 0.0004
458 PERONEAL NERVE PALSY 2 0.0004
459 GENERALISED ERYTHEMA 2 0.0004
460 ATRIAL FIBRILLATION 34 0.0003
461 PARANOIA 6 0.0003
462 EPISTAXIS 26 0.0003
463 EXERCISE TOLERANCE DECREASED 2 0.0003
464 HYPERTHYROIDISM 5 0.0003
465 PLEURAL EFFUSION 21 0.0003
466 ABDOMINAL DISTENSION 36 0.0003
467 VASCULITIS 4 0.0003
468 BODY TEMPERATURE INCREASED 7 0.0003
469 PURPURA 3 0.0003
470 GLUCOSE TOLERANCE IMPAIRED 2 0.0003
471 TACHYCARDIA 30 0.0003
472 PULMONARY HYPERTENSION 7 0.0003
473 CHOLECYSTITIS 4 0.0003
474 PRODUCTIVE COUGH 16 0.0003
475 GASTROINTESTINAL HAEMORRHAGE 28 0.0003
476 FLUSHING 34 0.0003
477 RESPIRATORY DISORDER 10 0.0003
478 GANGRENE 2 0.0003
479 RESTLESS LEGS SYNDROME 6 0.0003
480 SCHIZOPHRENIA 4 0.0003
481 INGUINAL HERNIA 2 0.0003
482 HAEMATOCHEZIA 18 0.0003
483 INCREASED TENDENCY TO BRUISE 3 0.0003
484 ENCEPHALOPATHY 8 0.0003
485 UROSEPSIS 3 0.0003
486 HYPOKALAEMIA 15 0.0003
487 SPINAL OPERATION 4 0.0003
488 SPEECH DISORDER 17 0.0003
489 MENTAL STATUS CHANGES 9 0.0003
490 TENDON RUPTURE 4 0.0003
491 FAECES DISCOLOURED 7 0.0003
492 CHOLANGITIS 2 0.0003
493 VAGINAL HAEMORRHAGE 14 0.0003
494 BLOOD ALKALINE PHOSPHATASE INCREASED 8 0.0003
495 SEPTIC SHOCK 14 0.0003
496 HEPATIC ENCEPHALOPATHY 3 0.0003
497 NEPHROPATHY 3 0.0003
498 APPENDICITIS 3 0.0003
499 BLOOD SODIUM DECREASED 6 0.0003
500 CELLULITIS 16 0.0003
501 DELIRIUM 11 0.0003
502 ARRHYTHMIA 15 0.0003
503 GASTRIC ULCER 6 0.0003
504 PULMONARY EMBOLISM 30 0.0003
505 PROTEINURIA 6 0.0003
506 HAEMATEMESIS 8 0.0003
507 HYPOPHAGIA 8 0.0003
508 PULMONARY FIBROSIS 6 0.0003
509 PULMONARY OEDEMA 14 0.0003
510 ERECTILE DYSFUNCTION 8 0.0003
511 UNRESPONSIVE TO STIMULI 8 0.0003
512 ANAEMIA 59 0.0003
513 MUSCULAR WEAKNESS 35 0.0003
514 LOWER RESPIRATORY TRACT INFECTION 14 0.0003
515 BLOOD PRESSURE INCREASED 47 0.0003
516 REFUSAL OF TREATMENT BY PATIENT 2 0.0003
517 HAEMOGLOBIN DECREASED 31 0.0003
518 CARDIAC FAILURE ACUTE 2 0.0003
519 GAIT INABILITY 10 0.0003
520 CHOLECYSTITIS CHRONIC 2 0.0003
521 EMPHYSEMA 3 0.0003
522 CONFUSIONAL STATE 48 0.0003
523 SUICIDE ATTEMPT 18 0.0003
524 LOSS OF CONSCIOUSNESS 38 0.0003
525 EYELID PTOSIS 3 0.0003
526 SUBARACHNOID HAEMORRHAGE 3 0.0003
527 MOTOR DYSFUNCTION 3 0.0003
528 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 53 0.0003
529 PERIPHERAL COLDNESS 4 0.0003
530 GYNAECOMASTIA 9 0.0003
531 RESPIRATION ABNORMAL 2 0.0003
532 HYPERBILIRUBINAEMIA 3 0.0003
533 LOCALISED INFECTION 7 0.0003
534 ABDOMINAL PAIN 67 0.0003
535 PANCYTOPENIA 16 0.0003
536 WOUND 8 0.0003
537 INJECTION SITE DISCOMFORT 3 0.0003
538 METASTASES TO LIVER 5 0.0003
539 SUDDEN DEATH 3 0.0003
540 CLOSTRIDIUM DIFFICILE COLITIS 3 0.0003
541 RETCHING 6 0.0003
542 JOINT INJURY 6 0.0003
543 OROPHARYNGEAL PAIN 26 0.0003
544 LETHARGY 16 0.0003
545 BLOOD CREATINE PHOSPHOKINASE INCREASED 8 0.0003
546 OSTEOMYELITIS 5 0.0003
547 DECREASED APPETITE 64 0.0003
548 FAECES SOFT 2 0.0003
549 RED BLOOD CELL SEDIMENTATION RATE INCREASED 3 0.0003
550 CARDIOMYOPATHY 4 0.0003
551 HYPOPHOSPHATAEMIA 2 0.0003
552 DEHYDRATION 36 0.0003
553 ARTHROPATHY 15 0.0003
554 FEELING DRUNK 2 0.0003
555 CATARACT 16 0.0003
556 INTERSTITIAL LUNG DISEASE 13 0.0003
557 COLITIS ULCERATIVE 12 0.0003
558 EYE INFECTION 3 0.0003
559 IMPAIRED DRIVING ABILITY 3 0.0003
560 OSTEOPENIA 4 0.0003
561 ASPARTATE AMINOTRANSFERASE INCREASED 14 0.0003
562 AORTIC ANEURYSM 2 0.0003
563 URTICARIA 44 0.0003
564 DRUG DISPENSING ERROR 4 0.0003
565 CARDIAC FAILURE CONGESTIVE 21 0.0003
566 LIPASE INCREASED 2 0.0003
567 NASOPHARYNGITIS 48 0.0003
568 HAEMOLYSIS 2 0.0003
569 OEDEMA 14 0.0003
570 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 2 0.0003
571 RENAL FAILURE 34 0.0003
572 MULTIPLE ALLERGIES 2 0.0003
573 DYSPNOEA 144 0.0003
574 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 18 0.0003
575 DISORIENTATION 10 0.0003
576 BLOOD ALBUMIN DECREASED 2 0.0003
577 INFLAMMATION 13 0.0003
578 RESPIRATORY TRACT CONGESTION 4 0.0003
579 ACCIDENT 3 0.0003
580 POLYNEUROPATHY 3 0.0003
581 DEMENTIA 7 0.0003
582 MIOSIS 2 0.0002
583 PALPITATIONS 29 0.0002
584 MYALGIA 42 0.0002
585 MUSCLE DISORDER 2 0.0002
586 FIBROMYALGIA 6 0.0002
587 NEURALGIA 6 0.0002
588 BACK DISORDER 4 0.0002
589 DEPRESSED MOOD 13 0.0002
590 DECUBITUS ULCER 2 0.0002
591 HAIR DISORDER 2 0.0002
592 PHOTOSENSITIVITY REACTION 4 0.0002
593 HEMIPLEGIA 2 0.0002
594 EYE PRURITUS 8 0.0002
595 RHEUMATOID ARTHRITIS 27 0.0002
596 UPPER GASTROINTESTINAL HAEMORRHAGE 4 0.0002
597 LABORATORY TEST ABNORMAL 7 0.0002
598 TRANSIENT ISCHAEMIC ATTACK 8 0.0002
599 ASTHENIA 89 0.0002
600 DIABETES MELLITUS 18 0.0002
601 OSTEOARTHRITIS 10 0.0002
602 GENERAL PHYSICAL HEALTH DETERIORATION 27 0.0002
603 BALANCE DISORDER 20 0.0002
604 CARDIAC MURMUR 2 0.0002
605 CARDIAC ARREST 19 0.0002
606 NODULE 3 0.0002
607 LOCAL SWELLING 4 0.0002
608 CONTUSION 22 0.0002
609 FEELING HOT 14 0.0002
610 ANHEDONIA 6 0.0002
611 ORAL CANDIDIASIS 3 0.0002
612 DEPRESSED LEVEL OF CONSCIOUSNESS 9 0.0002
613 LUNG INFILTRATION 2 0.0002
614 EYE HAEMORRHAGE 3 0.0002
615 SWOLLEN TONGUE 7 0.0002
616 ANAL INCONTINENCE 2 0.0002
617 WEIGHT DECREASED 62 0.0002
618 GASTROENTERITIS VIRAL 4 0.0002
619 OROPHARYNGEAL DISCOMFORT 2 0.0002
620 DIZZINESS 110 0.0002
621 DRUG TOXICITY 3 0.0002
622 IMPAIRED GASTRIC EMPTYING 3 0.0002
623 CYSTITIS 7 0.0002
624 END STAGE RENAL DISEASE 4 0.0002
625 EXOSTOSIS 2 0.0002
626 PRODUCT USE IN UNAPPROVED INDICATION 54 0.0002
627 MUSCULOSKELETAL STIFFNESS 19 0.0002
628 NERVE COMPRESSION 2 0.0002
629 IRON DEFICIENCY ANAEMIA 2 0.0002
630 FEELING COLD 6 0.0002
631 JOINT SWELLING 26 0.0002
632 SINUSITIS 22 0.0002
633 SOMNOLENCE 43 0.0002
634 VERTIGO 13 0.0002
635 IMPAIRED HEALING 7 0.0002
636 HEPATOCELLULAR INJURY 3 0.0002
637 HYPOCALCAEMIA 4 0.0002
638 THERAPEUTIC RESPONSE SHORTENED 7 0.0002
639 FOOT FRACTURE 4 0.0002
640 SYNCOPE 21 0.0002
641 CONVULSION 12 0.0002
642 URINARY RETENTION 7 0.0002
643 CHOLESTASIS 4 0.0002
644 POST PROCEDURAL COMPLICATION 4 0.0002
645 TYPE 2 DIABETES MELLITUS 7 0.0002
646 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 7 0.0002
647 ERUCTATION 4 0.0002
648 COMPLICATION ASSOCIATED WITH DEVICE 3 0.0002
649 DIZZINESS POSTURAL 2 0.0002
650 FLUID OVERLOAD 3 0.0002
651 RENAL TUBULAR NECROSIS 2 0.0002
652 BRONCHITIS 15 0.0002
653 URINARY INCONTINENCE 6 0.0002
654 OSTEONECROSIS OF JAW 5 0.0002
655 HYPOTONIA 2 0.0002
656 HYPOAESTHESIA ORAL 3 0.0002
657 PNEUMONIA 64 0.0002
658 DISCOMFORT 12 0.0002
659 DRUG LEVEL DECREASED 2 0.0002
660 CEREBRAL HAEMORRHAGE 7 0.0002
661 ALANINE AMINOTRANSFERASE INCREASED 12 0.0002
662 NEUTROPHIL COUNT INCREASED 2 0.0002
663 MYOCARDIAL INFARCTION 34 0.0002
664 LYMPHOMA 3 0.0002
665 MUSCULOSKELETAL CHEST PAIN 3 0.0002
666 PERITONITIS 4 0.0002
667 HAEMATOMA 5 0.0002
668 TREMOR 32 0.0002
669 ACUTE MYELOID LEUKAEMIA 3 0.0002
670 RHABDOMYOLYSIS 8 0.0002
671 PETECHIAE 2 0.0002
672 RESTLESSNESS 7 0.0002
673 MUSCULOSKELETAL PAIN 10 0.0002
674 PYREXIA 66 0.0002
675 JOINT STIFFNESS 5 0.0002
676 DYSURIA 7 0.0002
677 OCULAR HYPERAEMIA 9 0.0002
678 HALLUCINATION, VISUAL 4 0.0002
679 INCONTINENCE 2 0.0002
680 DISEASE RECURRENCE 9 0.0002
681 PANCREATITIS 10 0.0002
682 SCIATICA 3 0.0002
683 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 9 0.0002
684 FALL 62 0.0002
685 JAUNDICE 5 0.0002
686 BLOOD BILIRUBIN INCREASED 5 0.0002
687 PRURITUS GENERALISED 4 0.0002
688 ERYTHEMA 38 0.0002
689 THROAT TIGHTNESS 5 0.0002
690 PHARYNGITIS STREPTOCOCCAL 2 0.0002
691 PARAESTHESIA 29 0.0002
692 PULMONARY THROMBOSIS 2 0.0002
693 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
694 CHOLELITHIASIS 6 0.0002
695 METASTASES TO BONE 3 0.0002
696 INJECTION SITE NODULE 2 0.0002
697 RESPIRATORY ARREST 5 0.0002
698 FEBRILE NEUTROPENIA 12 0.0002
699 DENTAL CARIES 2 0.0002
700 FOOT DEFORMITY 2 0.0002
701 DRY EYE 9 0.0002
702 TRANSAMINASES INCREASED 4 0.0002
703 FACE OEDEMA 3 0.0002
704 ABNORMAL BEHAVIOUR 7 0.0002
705 PAIN IN JAW 5 0.0002
706 HAEMATURIA 6 0.0002
707 MICTURITION URGENCY 2 0.0002
708 CHOLECYSTECTOMY 2 0.0002
709 RED BLOOD CELL COUNT DECREASED 5 0.0002
710 CONDITION AGGRAVATED 53 0.0002
711 SHOCK 4 0.0002
712 GASTROOESOPHAGEAL REFLUX DISEASE 14 0.0002
713 PERICARDIAL EFFUSION 4 0.0002
714 ELECTROLYTE IMBALANCE 2 0.0002
715 UNEVALUABLE EVENT 13 0.0002
716 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 4 0.0002
717 CHILLS 20 0.0002
718 THROMBOCYTOPENIA 19 0.0002
719 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
720 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
721 HEAD DISCOMFORT 3 0.0002
722 NEUROLEPTIC MALIGNANT SYNDROME 2 0.0002
723 ARTHRALGIA 70 0.0002
724 MACULAR DEGENERATION 2 0.0002
725 GOUT 3 0.0002
726 ELECTROCARDIOGRAM QT PROLONGED 6 0.0002
727 PRODUCT DOSE OMISSION ISSUE 49 0.0002
728 DIABETIC KETOACIDOSIS 4 0.0002
729 RASH PRURITIC 9 0.0002
730 CHEST DISCOMFORT 17 0.0002
731 INFUSION RELATED REACTION 11 0.0002
732 APHASIA 5 0.0002
733 ANXIETY 47 0.0002
734 CORONARY ARTERY DISEASE 5 0.0002
735 DIARRHOEA 106 0.0002
736 NO THERAPEUTIC RESPONSE 2 0.0002
737 RECTAL HAEMORRHAGE 7 0.0002
738 HYPOACUSIS 7 0.0002
739 ABASIA 4 0.0002
740 AGRANULOCYTOSIS 3 0.0002
741 PHARYNGITIS 2 0.0002
742 WEIGHT INCREASED 36 0.0002
743 INTENTIONAL PRODUCT USE ISSUE 14 0.0002
744 HEPATIC CIRRHOSIS 3 0.0002
745 PHOTOPHOBIA 3 0.0002
746 DRUG-INDUCED LIVER INJURY 5 0.0002
747 FATIGUE 124 0.0002
748 POISONING 2 0.0002
749 GLYCOSYLATED HAEMOGLOBIN INCREASED 4 0.0002
750 COLITIS 6 0.0002
751 ABDOMINAL PAIN LOWER 4 0.0002
752 HEAD INJURY 5 0.0002
753 WHITE BLOOD CELL COUNT DECREASED 17 0.0002
754 WHITE BLOOD CELL COUNT INCREASED 6 0.0002
755 BACK PAIN 36 0.0002
756 ORAL HERPES 3 0.0002
757 PLATELET COUNT INCREASED 2 0.0002
758 NEPHROLITHIASIS 7 0.0002
759 HAND DEFORMITY 2 0.0002
760 DYSPEPSIA 15 0.0002
761 BEDRIDDEN 2 0.0002
762 WHEEZING 9 0.0002
763 ACTIVITIES OF DAILY LIVING IMPAIRED 3 0.0002
764 EAR INFECTION 4 0.0002
765 LIP SWELLING 5 0.0001
766 SKIN DISORDER 5 0.0001
767 PAIN IN EXTREMITY 44 0.0001
768 FEAR 4 0.0001
769 INTENTIONAL PRODUCT MISUSE 13 0.0001
770 MALAISE 65 0.0001
771 FREQUENT BOWEL MOVEMENTS 4 0.0001
772 RASH ERYTHEMATOUS 7 0.0001
773 SKIN LESION 4 0.0001
774 ROAD TRAFFIC ACCIDENT 6 0.0001
775 CARPAL TUNNEL SYNDROME 2 0.0001
776 PERIPHERAL SWELLING 22 0.0001
777 COVID-19 25 0.0001
778 INJURY 10 0.0001
779 DISSEMINATED INTRAVASCULAR COAGULATION 2 0.0001
780 INTENTIONAL DOSE OMISSION 4 0.0001
781 BRONCHOSPASM 2 0.0001
782 IRRITABLE BOWEL SYNDROME 3 0.0001
783 NEUTROPENIA 19 0.0001
784 HYPERHIDROSIS 18 0.0001
785 PARALYSIS 2 0.0001
786 SWELLING FACE 9 0.0001
787 OFF LABEL USE 121 0.0001
788 INFECTION 20 0.0001
789 DRUG EFFECT INCOMPLETE 5 0.0001
790 CONSTIPATION 30 0.0001
791 PANIC ATTACK 5 0.0001
792 APATHY 2 0.0001
793 NASAL CONGESTION 8 0.0001
794 GAIT DISTURBANCE 26 0.0001
795 CEREBROVASCULAR ACCIDENT 23 0.0001
796 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
797 URINARY TRACT INFECTION 23 0.0001
798 HEPATOTOXICITY 3 0.0001
799 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 7 0.0001
800 ORAL PAIN 3 0.0001
801 RASH PAPULAR 3 0.0001
802 HAEMORRHAGE INTRACRANIAL 2 0.0001
803 CHROMATURIA 3 0.0001
804 DYSARTHRIA 5 0.0001
805 CONTRAINDICATED PRODUCT ADMINISTERED 4 0.0001
806 COMPLETED SUICIDE 11 0.0001
807 ECONOMIC PROBLEM 2 0.0001
808 BLOOD COUNT ABNORMAL 2 0.0001
809 CHRONIC KIDNEY DISEASE 10 0.0001
810 SUICIDAL IDEATION 12 0.0001
811 HIP ARTHROPLASTY 2 0.0001
812 DRUG ADMINISTRATION ERROR 4 0.0001
813 UPPER RESPIRATORY TRACT INFECTION 6 0.0001
814 CHEST PAIN 24 0.0001
815 LIMB DISCOMFORT 4 0.0001
816 FEMUR FRACTURE 4 0.0001
817 RENAL DISORDER 6 0.0001
818 BLOOD CHOLESTEROL INCREASED 6 0.0001
819 BASAL CELL CARCINOMA 2 0.0001
820 TREATMENT NONCOMPLIANCE 7 0.0001
821 CYANOSIS 2 0.0001
822 ANAPHYLACTIC REACTION 7 0.0001
823 OVERDOSE 27 0.0001
824 BLISTER 7 0.0001
825 PROSTATE CANCER 10 0.0001
826 FLATULENCE 7 0.0001
827 PRESYNCOPE 3 0.0001
828 DYSKINESIA 5 0.0001
829 GASTROINTESTINAL DISORDER 11 0.0001
830 AGITATION 9 0.0001
831 LIVER INJURY 3 0.0001
832 BLOOD GLUCOSE INCREASED 23 0.0001
833 STAPHYLOCOCCAL INFECTION 4 0.0001
834 VOMITING 57 0.0001
835 TREATMENT FAILURE 10 0.0001
836 PERICARDITIS 2 0.0001
837 HEMIPARESIS 2 0.0001
838 HEPATIC ENZYME INCREASED 8 0.0001
839 HEPATITIS 3 0.0001
840 MALIGNANT NEOPLASM PROGRESSION 12 0.0001
841 MUSCULOSKELETAL DISCOMFORT 2 0.0001
842 SKIN ULCER 3 0.0001
843 PHARMACEUTICAL PRODUCT COMPLAINT 3 0.0001
844 RESPIRATORY TRACT INFECTION 3 0.0001
845 NEOPLASM PROGRESSION 4 0.0001
846 RASH MACULAR 4 0.0001
847 NEUROTOXICITY 2 0.0001
848 EOSINOPHILIA 2 0.0001
849 DEVICE MALFUNCTION 8 0.0001
850 ISCHAEMIC STROKE 2 0.0001
851 MYELOSUPPRESSION 4 0.0001
852 HEART RATE INCREASED 11 0.0001
853 LIMB INJURY 3 0.0001
854 PNEUMONITIS 3 0.0001
855 HYPERGLYCAEMIA 4 0.0001
856 BONE DISORDER 2 0.0001
857 NAUSEA 86 0.0001
858 BLOOD GLUCOSE ABNORMAL 2 0.0001
859 HYPERSENSITIVITY 20 0.0001
860 AMNESIA 7 0.0001
861 NECK PAIN 6 0.0001
862 MIDDLE INSOMNIA 2 0.0001
863 HEADACHE 67 0.0001
864 PRURITUS 41 0.0001
865 INCORRECT DRUG ADMINISTRATION DURATION 3 0.0001
866 HALLUCINATION 8 0.0001
867 MUSCULOSKELETAL DISORDER 2 0.0001
868 PRODUCT SUBSTITUTION ISSUE 6 0.0001
869 DRUG PRESCRIBING ERROR 2 0.0001
870 ACUTE RESPIRATORY FAILURE 2 0.0001
871 GLAUCOMA 2 0.0001
872 HERNIA 2 0.0001
873 EAR PAIN 2 0.0001
874 DYSSTASIA 3 0.0001
875 ASCITES 3 0.0001
876 KIDNEY INFECTION 2 0.0001
877 MEMORY IMPAIRMENT 14 0.0001
878 RENAL INJURY 3 0.0001
879 HYPOAESTHESIA 15 0.0001
880 LEUKOPENIA 5 0.0001
881 BURNING SENSATION 7 0.0001
882 BLOOD POTASSIUM DECREASED 3 0.0001
883 THROMBOSIS 8 0.0001
884 FULL BLOOD COUNT DECREASED 2 0.0001
885 INFLUENZA 11 0.0001
886 NEUTROPHIL COUNT DECREASED 4 0.0001
887 PAIN 60 0.0001
888 PRODUCT PREPARATION ERROR 2 0.0001
889 SWELLING 9 0.0001
890 NERVOUS SYSTEM DISORDER 3 0.0001
891 POLLAKIURIA 4 0.0001
892 BONE DENSITY DECREASED 3 0.0001
893 NERVOUSNESS 5 0.0001
894 NEUROPATHY PERIPHERAL 9 0.0001
895 DYSGEUSIA 7 0.0001
896 HYPOTHYROIDISM 3 0.0001
897 HOT FLUSH 7 0.0001
898 DISTURBANCE IN ATTENTION 5 0.0001
899 DEPRESSION 21 0.0001
900 MENTAL DISORDER 4 0.0001
901 PRODUCT DOSE OMISSION 6 0.0001
902 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
903 EMOTIONAL DISTRESS 11 0.0001
904 ABDOMINAL DISCOMFORT 15 0.0001
905 GLOSSODYNIA 2 0.0001
906 THERAPEUTIC RESPONSE UNEXPECTED 4 0.0001
907 APPLICATION SITE PRURITUS 2 0.0001
908 MUSCLE SPASMS 16 0.0001
909 RASH 38 0.0001
910 SKIN DISCOLOURATION 4 0.0001
911 MUSCLE TWITCHING 2 0.0001
912 SEIZURE 10 0.0001
913 HAEMORRHAGE 9 0.0001
914 INFLUENZA LIKE ILLNESS 7 0.0001
915 LYMPHADENOPATHY 3 0.0001
916 PLATELET COUNT DECREASED 9 0.0001
917 FEELING ABNORMAL 20 0.0001
918 INSOMNIA 22 0.0001
919 ABDOMINAL PAIN UPPER 17 0.0001
920 ACCIDENTAL OVERDOSE 3 0.0001
921 VISUAL IMPAIRMENT 10 0.0001
922 HEPATIC FUNCTION ABNORMAL 3 0.0001
923 INTESTINAL OBSTRUCTION 3 0.0001
924 DRUG RESISTANCE 2 0.0001
925 RASH GENERALISED 2 0.0001
926 DEEP VEIN THROMBOSIS 5 0.0001
927 DEAFNESS 2 0.0001
928 MUCOSAL INFLAMMATION 2 0.0001
929 APPLICATION SITE ERYTHEMA 2 0.0001
930 BREAST CANCER FEMALE 2 0.0001
931 CARDIAC DISORDER 7 0.0001
932 PSORIATIC ARTHROPATHY 3 0.0001
933 BLINDNESS 3 0.0001
934 MIGRAINE 7 0.0001
935 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
936 PROCEDURAL PAIN 2 0.0001
937 SEPSIS 8 0.0001
938 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 5 0.0001
939 PANCREATIC CARCINOMA 2 0.0001
940 DEVICE DISLOCATION 3 0.0001
941 LIVER FUNCTION TEST ABNORMAL 2 0.0001
942 UNDERDOSE 5 0.0001
943 BONE PAIN 4 0.0001
944 ILLNESS 7 0.0001
945 DISEASE PROGRESSION 8 0.0001
946 ALOPECIA 13 0.0001
947 DRUG INEFFECTIVE 87 0.0001
948 ILL-DEFINED DISORDER 4 0.0001
949 EPILEPSY 2 0.0001
950 TINNITUS 3 0.0001
951 INJECTION SITE RASH 2 0.0001
952 EMOTIONAL DISORDER 2 0.0001
953 DYSPHAGIA 6 0.0001
954 MOVEMENT DISORDER 2 0.0001
955 RHINORRHOEA 4 0.0001
956 DRY MOUTH 5 0.0001
957 INCORRECT DOSE ADMINISTERED 14 0.0001
958 EYE DISORDER 2 0.0001
959 INJECTION SITE PRURITUS 4 0.0001
960 FLUID RETENTION 3 0.0001
961 VISION BLURRED 8 0.0001
962 INJECTION SITE REACTION 4 0.0001
963 NIGHTMARE 2 0.0001
964 ECZEMA 3 0.0001
965 PRODUCT ADHESION ISSUE 2 0.0001
966 THERAPY INTERRUPTED 4 0.0001
967 EYE PAIN 3 0.0001
968 ASTHMA 6 0.0001
969 EYE IRRITATION 3 0.0001
970 DRUG INTOLERANCE 5 0.0001
971 PLASMA CELL MYELOMA 2 0.0001
972 THERAPEUTIC RESPONSE DECREASED 3 0.0000
973 DEATH 39 0.0000
974 NEOPLASM MALIGNANT 3 0.0000
975 ADVERSE EVENT 4 0.0000
976 COGNITIVE DISORDER 2 0.0000
977 PSORIASIS 5 0.0000
978 INJECTION SITE BRUISING 3 0.0000
979 PRODUCT USE ISSUE 7 0.0000
980 PRODUCT QUALITY ISSUE 5 0.0000
981 MEDICATION ERROR 2 0.0000
982 INJECTION SITE PAIN 11 0.0000
983 SKIN EXFOLIATION 3 0.0000
984 INJECTION SITE ERYTHEMA 4 0.0000
985 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
986 HOSPITALISATION 4 0.0000
987 INJECTION SITE HAEMORRHAGE 2 0.0000
988 DRUG DOSE OMISSION 4 0.0000
989 DRY SKIN 3 0.0000
990 ADVERSE DRUG REACTION 2 0.0000
991 NO ADVERSE EVENT 3 0.0000